REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts24132828
Avg. Estimate4.493.9315.6517.22
Low Estimate2.95313.9913.48
High Estimate5.134.4916.6320.95
Year Ago EPS3.042.9211.3215.65
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts22142626
Avg. Estimate1.49B1.49B5.78B6.23B
Low Estimate1.41B1.29B5.69B5.42B
High Estimate1.6B1.58B5.92B6.76B
Year Ago Sales1.23B1.32B4.86B5.78B
Sales Growth (year/est)21.80%13.00%18.90%7.80%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.3.033.063.173.85
EPS Actual3.042.924.173.99
Difference0.01-0.1410.14
Surprise %0.30%-4.60%31.50%3.60%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate4.493.9315.6517.22
7 Days Ago4.493.8815.6417.01
30 Days Ago4.53.8315.5916.79
60 Days Ago4.483.8515.5816.84
90 Days Ago3.983.7314.9416.47
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 Days1213
Up Last 30 Days1439
Down Last 30 Days1N/A1N/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesREGNIndustrySectorS&P 500
Current Qtr.47.70%N/AN/A0.26
Next Qtr.34.60%N/AN/A0.33
Current Year38.30%N/AN/A0.09
Next Year10.00%N/AN/A0.15
Next 5 Years (per annum)17.44%N/AN/A0.11
Past 5 Years (per annum)30.58%N/AN/AN/A